Papers: 5 Nov 2012 - 12 Nov 2012 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun. Li C, Ma J, Zhao H, Blagg BSJ, Dobrowsky RT ASN Neuro. 2012 Nov 6. PMID: 23130605. Abstract Editors' Pick Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, et al. Lancet. 2012 Oct 31. PMID: 23122650. Abstract Editors' Pick Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, Fisher E, et al. Lancet. 2012 Oct 31. PMID: 23122652. Abstract Editors' Pick Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis. Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S, Lepore V, Grand'Maison F, Duquette P, Izquierdo G, Grammond P, et al. PLoS One. 2012; 7(10):e48078. Epub 2012 Oct 25. PMID: 23133550. Abstract The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis. Alschuler KN, Jensen MP, Ehde DM Pain Med. 2012 Nov 8. PMID: 23137071. Abstract Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Al-Radaideh AM, Wharton SJ, Lim S-Y, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA Mult Scler. 2012 Nov 8. PMID: 23139386. Abstract Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope. Pandey S, Dioni I, Lambardi D, Real-Fernandez F, Peroni E, Pacini G, Lolli F, Seraglia R, Papini A M, Rovero P Mol Cell Proteomics. 2012 Nov 8. PMID: 23139387. Abstract Hormone and immune system interactions in demyelinating disease. Gomez FP, Steelman AJ, Young CR, Welsh JC Horm Behav. 2012 Nov 5. PMID: 23137721. Abstract Rituximab combination therapy in relapsing multiple sclerosis. Cross AH, Klein RS, Piccio L Ther Adv Neurol Disord. 2012 Nov; 5(6):311-9. PMID: 23139702. Abstract Optic neuritis: A blurry issue. Bhatia R, Singhal A Neurol India. 2012 Sep-Oct; 60(5):459-60. PMID: 23135019. Abstract [Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?]. Jensen R M, Tfelt-Hansen P Ugeskr Laeger. 2012 Sep 10; 174(37):2179; discussion 2179. PMID: 23136644. Abstract Optic neuritis: Experience from a south Indian demyelinating disease registry. Pandit L, Shetty R, Misri Z, Bhat S, Amin H, Pai V, Rao R Neurol India. 2012 Sep-Oct; 60(5):470-5. PMID: 23135022. Abstract Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord. Condie AG, Gerson SL, Miller RH, Wang Y ChemMedChem. 2012 Nov 7. PMID: 23136014. Abstract A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Kelly S, Kinsella K, Duggan M, Tubridy N, McGuigan C, Hutchinson M Mult Scler. 2012 Nov 6. PMID: 23132903. Abstract Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study. Cabre P, Olindo S, Marignier R, Jeannin S, Merle H, Smadja D, Aegis of French National Observatory of Multiple Sclerosis J Neurol Neurosurg Psychiatry. 2013 May; 84(5):511-6. Epub 2012 Nov 08. PMID: 23138769. Abstract Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy. Tourdias T, Dousset V Neurotherapeutics. 2012 Nov 7. PMID: 23132327. Abstract Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment. Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S Mult Scler. 2012 Nov 6. PMID: 23132904. Abstract Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities. Lian Y-T, Yang X-F, Wang Z-H, Yang Y, Yang Y, Shu Y-W, Cheng L-X, Liu K Phytother Res. 2012 Nov 7. PMID: 23132777. Abstract Multi-slice myelin water imaging for practical clinical applications at 3.0 T. Guo J, Ji Q, Reddick WE Magn Reson Med. 2012 Nov 6. PMID: 23132434. Abstract Myelination: Do Astrocytes Play a Role? Barnett SC, Linington C Neuroscientist. 2012 Nov 6. PMID: 23131748. Abstract Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration. Katsouri L, Blondrath K, Sastre M IUBMB Life. 2012 Nov 6. PMID: 23129362. Abstract Phosphodiesterases in neurodegenerative disorders. Bollen E, Prickaerts J IUBMB Life. 2012 Nov 5. PMID: 23129425. Abstract Cancer drug shows promise for multiple sclerosis. BMJ. 2012; 345:e7469. PMID: 23129493. Abstract Brain iron deposition in white matter hyperintensities: a 3-T MRI study. Yan S, Sun J, Chen Y, Selim M, Lou M Age (Dordr). 2012 Nov 7. Epub 2012 Nov 07. PMID: 23129024. Abstract Alemtuzumab for multiple sclerosis: who and when to treat? Sprenger T, Kappos L Lancet. 2012 Nov 2. PMID: 23128041. Abstract Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial. Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S Mult Scler. 2012 Nov 5. PMID: 23128667. Abstract Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, Reindl M, Gärtner J Mult Scler. 2012 Nov 5. PMID: 23128668. Abstract Natalizumab: Bench to Bedside and Beyond. Rudick R, Polman C, Clifford D, Miller D, Steinman L Arch Neurol. 2012 Nov 5:1-11. PMID: 23128399. Abstract Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis. Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, et al. Arch Neurol. 2012 Nov 5:1-4. PMID: 23128366. Abstract Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis. Adamec I, Bach I, Barušić A K, Mišmaš A, Habek M J Neurol Sci. 2012 Nov 2. PMID: 23127354. Abstract Falls in people with MS who use a walking aid: Prevalence, factors and effect of balance and strengthening interventions. Coote S, Hogan N, Franklin S Arch Phys Med Rehabil. 2012 Nov 2. PMID: 23127308. Abstract Multiple sclerosis coexisting with spinal cord ependymoma: a case report. Degirmenci E Ideggyogy Sz. 2012 Sep 30; 65(9-10):342-4. PMID: 23126220. Abstract Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis. Kraemer M, Herold M, Uekermann J, Kis B, Daum I, Wiltfang J, Berlit P, Diehl RR, Abdel-Hamid M J Neuropsychol. 2012 Nov 5. PMID: 23126275. Abstract Health status and costs of ambulatory patients with multiple sclerosis in Hungary. Péntek M, Gulácsi L, Rózsa C, Simó M, Iljicsov A, Komoly S, Brodszky V Ideggyogy Sz. 2012 Sep 30; 65(9-10):316-24. PMID: 23126217. Abstract Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients. Hikita K, Honda M, Kawamoto B, Panagiota T, Inoue S, Hinata N, Muraoka K, Takenaka A Int J Urol. 2012 Nov 6. PMID: 23126535. Abstract Footfall Placement Variability and Falls in Multiple Sclerosis. Socie MJ, Sandroff BM, Pula JH, Hsiao-Wecksler ET, Motl RW, Sosnoff JJ Ann Biomed Eng. 2012 Nov 7. Epub 2012 Nov 07. PMID: 23132152. Abstract Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity. Sweet RA, Lee SK, Vinuesa CG Curr Opin Immunol. 2012 Nov 1. PMID: 23123277. Abstract Understanding hope in patients with Multiple Sclerosis. Soundy A, Benson J, Dawes H, Smith B, Collett J, Meaney A Physiotherapy. 2012 Dec; 98(4):349-55. PMID: 23122442. Abstract Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis. Bender MT, Pradilla G, Batra S, See AP, James C, Pardo CA, Carson BS, Lim M J Neurosurg. 2012 Nov 2. PMID: 23121430. Abstract Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis. Pulinx B, Hupperts RMM, Vogt MH, Ten Kate J, van Dieijen-Visser MP, Wodzig WKWH Clin Chem Lab Med. 2012 Sep; 50(9):1693-5. PMID: 23125996. Abstract [Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis]. Vestn Oftalmol. 2012 May-Jun; 128(3):6-10. PMID: 23120916. Abstract Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances. Egeberg MD, Oh CY, Bainbridge JL Clin Ther. 2012 Nov 1. PMID: 23123001. Abstract Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice. Yang JF, Tao HQ, Liu YM, Zhan XX, Liu Y, Wang XY, Wang JH, Mu LL, Yang LL, Gao ZM, et al. Clin Exp Immunol. 2012 Dec; 170(3):254-65. PMID: 23121666. Abstract Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis. Ueno K-I, Matsushima A, Hineno A, Fukushima K, Tazawa K-I, Matsuda M, Ikeda S-I Mod Rheumatol. 2012 Nov 3. PMID: 23124610. Abstract Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Wang K-C, Tsai C-P, Lee C-L, Chen S-Y, Chin L-T, Chen S-J Neuroscience. 2012 Dec 13; 226:510-6. PMID: 23122444. Abstract Mesenchymal stem cells as treatment for MS - progress to date. Uccelli A, Laroni A, Freedman MS Mult Scler. 2012 Nov 1. PMID: 23124791. Abstract MAIT cells in autoimmunity. Miyake S Nihon Rinsho Meneki Gakkai Kaishi. 2012; 35(5):393-8. PMID: 23124081. Abstract A Qualitative Study of Nutritional Behaviors in Adults With Multiple Sclerosis. Plow M, Finlayson M J Neurosci Nurs. 2012 Dec; 44(6):337-350. PMID: 23124124. Abstract Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group" Havla J, Berthele A, Kümpfel T, Krumbholz M, Jochim A, Kronsbein H, Ryschkewitsch C, Jensen P, Lippmann K, Hemmer B, et al. Mult Scler. 2012 Nov 1. PMID: 23124790. Abstract Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom A-M, Malmeström C, et al. Mult Scler. 2012 Nov 1. PMID: 23124789. Abstract Alemtuzumab for multiple sclerosis. Lancet. 2012 Oct 31. PMID: 23122653. Abstract Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis. Mori F, Nicoletti CG, Kusayanagi H, Foti C, Restivo DA, Marciani M G, Centonze D Brain Stimul. 2012 Oct 27. PMID: 23122918. Abstract Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL Eur J Pharmacol. 2012 Oct 30. PMID: 23123057. Abstract Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein. Inglis HR, Greer JM, McCombe PA PLoS One. 2012; 7(11):e48555. Epub 2012 Nov 06. PMID: 23139791. Abstract Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men. Gacesa JZ, Momcilovic M, Veselinovic I, Brodie DA, Grujic NG BMC Musculoskelet Disord. 2012 Nov 6; 13(1):217. Epub 2012 Nov 06. PMID: 23127247. Abstract Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial. Saxton JM, Carter A, Daley AJ, Snowdon N, Woodroofe MN, Petty J, Roalfe A, Tosh J, Sharrack B Contemp Clin Trials. 2012 Nov 1. PMID: 23123791. Abstract The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis. Newland PK, Thomas FP, Riley M, Flick LH, Fearing A J Neurosci Nurs. 2012 Dec; 44(6):351-357. PMID: 23124125. Abstract Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study. Quispe-Cabanillas JG, Damasceno A, Glehn F, Brandão CO, Damasceno BP, Silveira WD, Santos LM BMC Complement Altern Med. 2012 Nov 5; 12(1):209. Epub 2012 Nov 05. PMID: 23126260. Abstract Risk of fractures in patients with multiple sclerosis: record-linkage study. Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ BMC Neurol. 2012 Nov 5; 12(1):135. Epub 2012 Nov 05. PMID: 23126555. Abstract The pathological and physiological roles of IL-6 amplifier activation. Murakami M, Hirano T Int J Biol Sci. 2012; 8(9):1267-80. Epub 2012 Oct 25. PMID: 23136555. Abstract Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study. Ernst A, Botzung A, Gounot D, Sellal F, Blanc F, de Seze J, Manning L Mult Scler Int. 2012; 2012:820240. Epub 2012 Oct 18. PMID: 23125932. Abstract Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series. Patil NJ, Nagaratna R, Garner C, Raghuram NV, Crisan R Complement Ther Med. 2012 Dec; 20(6):424-30. Epub 2012 Oct 09. PMID: 23131373. Abstract Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report. Peponis VG, Chatziralli IP, Parikakis EA, Chaira N, Katzakis MC, Mitropoulos PG Case Report Ophthalmol. 2012 Sep; 3(3):327-32. Epub 2012 Oct 06. PMID: 23139677. Abstract H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis. Saligrama N, Noubade R, Case LK, Poynter ME, Teuscher C Cell Immunol. 2012 Jul; 278(1-2):27-34. Epub 2012 Jul 14. PMID: 23121973. Abstract
Editors' Pick Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun. Li C, Ma J, Zhao H, Blagg BSJ, Dobrowsky RT ASN Neuro. 2012 Nov 6. PMID: 23130605. Abstract
Editors' Pick Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, et al. Lancet. 2012 Oct 31. PMID: 23122650. Abstract
Editors' Pick Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, Fisher E, et al. Lancet. 2012 Oct 31. PMID: 23122652. Abstract
Editors' Pick Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis. Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S, Lepore V, Grand'Maison F, Duquette P, Izquierdo G, Grammond P, et al. PLoS One. 2012; 7(10):e48078. Epub 2012 Oct 25. PMID: 23133550. Abstract
The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis. Alschuler KN, Jensen MP, Ehde DM Pain Med. 2012 Nov 8. PMID: 23137071. Abstract
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Al-Radaideh AM, Wharton SJ, Lim S-Y, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA Mult Scler. 2012 Nov 8. PMID: 23139386. Abstract
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope. Pandey S, Dioni I, Lambardi D, Real-Fernandez F, Peroni E, Pacini G, Lolli F, Seraglia R, Papini A M, Rovero P Mol Cell Proteomics. 2012 Nov 8. PMID: 23139387. Abstract
Hormone and immune system interactions in demyelinating disease. Gomez FP, Steelman AJ, Young CR, Welsh JC Horm Behav. 2012 Nov 5. PMID: 23137721. Abstract
Rituximab combination therapy in relapsing multiple sclerosis. Cross AH, Klein RS, Piccio L Ther Adv Neurol Disord. 2012 Nov; 5(6):311-9. PMID: 23139702. Abstract
Optic neuritis: A blurry issue. Bhatia R, Singhal A Neurol India. 2012 Sep-Oct; 60(5):459-60. PMID: 23135019. Abstract
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?]. Jensen R M, Tfelt-Hansen P Ugeskr Laeger. 2012 Sep 10; 174(37):2179; discussion 2179. PMID: 23136644. Abstract
Optic neuritis: Experience from a south Indian demyelinating disease registry. Pandit L, Shetty R, Misri Z, Bhat S, Amin H, Pai V, Rao R Neurol India. 2012 Sep-Oct; 60(5):470-5. PMID: 23135022. Abstract
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord. Condie AG, Gerson SL, Miller RH, Wang Y ChemMedChem. 2012 Nov 7. PMID: 23136014. Abstract
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Kelly S, Kinsella K, Duggan M, Tubridy N, McGuigan C, Hutchinson M Mult Scler. 2012 Nov 6. PMID: 23132903. Abstract
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study. Cabre P, Olindo S, Marignier R, Jeannin S, Merle H, Smadja D, Aegis of French National Observatory of Multiple Sclerosis J Neurol Neurosurg Psychiatry. 2013 May; 84(5):511-6. Epub 2012 Nov 08. PMID: 23138769. Abstract
Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy. Tourdias T, Dousset V Neurotherapeutics. 2012 Nov 7. PMID: 23132327. Abstract
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment. Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S Mult Scler. 2012 Nov 6. PMID: 23132904. Abstract
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities. Lian Y-T, Yang X-F, Wang Z-H, Yang Y, Yang Y, Shu Y-W, Cheng L-X, Liu K Phytother Res. 2012 Nov 7. PMID: 23132777. Abstract
Multi-slice myelin water imaging for practical clinical applications at 3.0 T. Guo J, Ji Q, Reddick WE Magn Reson Med. 2012 Nov 6. PMID: 23132434. Abstract
Myelination: Do Astrocytes Play a Role? Barnett SC, Linington C Neuroscientist. 2012 Nov 6. PMID: 23131748. Abstract
Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration. Katsouri L, Blondrath K, Sastre M IUBMB Life. 2012 Nov 6. PMID: 23129362. Abstract
Phosphodiesterases in neurodegenerative disorders. Bollen E, Prickaerts J IUBMB Life. 2012 Nov 5. PMID: 23129425. Abstract
Brain iron deposition in white matter hyperintensities: a 3-T MRI study. Yan S, Sun J, Chen Y, Selim M, Lou M Age (Dordr). 2012 Nov 7. Epub 2012 Nov 07. PMID: 23129024. Abstract
Alemtuzumab for multiple sclerosis: who and when to treat? Sprenger T, Kappos L Lancet. 2012 Nov 2. PMID: 23128041. Abstract
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial. Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S Mult Scler. 2012 Nov 5. PMID: 23128667. Abstract
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, Reindl M, Gärtner J Mult Scler. 2012 Nov 5. PMID: 23128668. Abstract
Natalizumab: Bench to Bedside and Beyond. Rudick R, Polman C, Clifford D, Miller D, Steinman L Arch Neurol. 2012 Nov 5:1-11. PMID: 23128399. Abstract
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis. Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, et al. Arch Neurol. 2012 Nov 5:1-4. PMID: 23128366. Abstract
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis. Adamec I, Bach I, Barušić A K, Mišmaš A, Habek M J Neurol Sci. 2012 Nov 2. PMID: 23127354. Abstract
Falls in people with MS who use a walking aid: Prevalence, factors and effect of balance and strengthening interventions. Coote S, Hogan N, Franklin S Arch Phys Med Rehabil. 2012 Nov 2. PMID: 23127308. Abstract
Multiple sclerosis coexisting with spinal cord ependymoma: a case report. Degirmenci E Ideggyogy Sz. 2012 Sep 30; 65(9-10):342-4. PMID: 23126220. Abstract
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis. Kraemer M, Herold M, Uekermann J, Kis B, Daum I, Wiltfang J, Berlit P, Diehl RR, Abdel-Hamid M J Neuropsychol. 2012 Nov 5. PMID: 23126275. Abstract
Health status and costs of ambulatory patients with multiple sclerosis in Hungary. Péntek M, Gulácsi L, Rózsa C, Simó M, Iljicsov A, Komoly S, Brodszky V Ideggyogy Sz. 2012 Sep 30; 65(9-10):316-24. PMID: 23126217. Abstract
Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients. Hikita K, Honda M, Kawamoto B, Panagiota T, Inoue S, Hinata N, Muraoka K, Takenaka A Int J Urol. 2012 Nov 6. PMID: 23126535. Abstract
Footfall Placement Variability and Falls in Multiple Sclerosis. Socie MJ, Sandroff BM, Pula JH, Hsiao-Wecksler ET, Motl RW, Sosnoff JJ Ann Biomed Eng. 2012 Nov 7. Epub 2012 Nov 07. PMID: 23132152. Abstract
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity. Sweet RA, Lee SK, Vinuesa CG Curr Opin Immunol. 2012 Nov 1. PMID: 23123277. Abstract
Understanding hope in patients with Multiple Sclerosis. Soundy A, Benson J, Dawes H, Smith B, Collett J, Meaney A Physiotherapy. 2012 Dec; 98(4):349-55. PMID: 23122442. Abstract
Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis. Bender MT, Pradilla G, Batra S, See AP, James C, Pardo CA, Carson BS, Lim M J Neurosurg. 2012 Nov 2. PMID: 23121430. Abstract
Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis. Pulinx B, Hupperts RMM, Vogt MH, Ten Kate J, van Dieijen-Visser MP, Wodzig WKWH Clin Chem Lab Med. 2012 Sep; 50(9):1693-5. PMID: 23125996. Abstract
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis]. Vestn Oftalmol. 2012 May-Jun; 128(3):6-10. PMID: 23120916. Abstract
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances. Egeberg MD, Oh CY, Bainbridge JL Clin Ther. 2012 Nov 1. PMID: 23123001. Abstract
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice. Yang JF, Tao HQ, Liu YM, Zhan XX, Liu Y, Wang XY, Wang JH, Mu LL, Yang LL, Gao ZM, et al. Clin Exp Immunol. 2012 Dec; 170(3):254-65. PMID: 23121666. Abstract
Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis. Ueno K-I, Matsushima A, Hineno A, Fukushima K, Tazawa K-I, Matsuda M, Ikeda S-I Mod Rheumatol. 2012 Nov 3. PMID: 23124610. Abstract
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Wang K-C, Tsai C-P, Lee C-L, Chen S-Y, Chin L-T, Chen S-J Neuroscience. 2012 Dec 13; 226:510-6. PMID: 23122444. Abstract
Mesenchymal stem cells as treatment for MS - progress to date. Uccelli A, Laroni A, Freedman MS Mult Scler. 2012 Nov 1. PMID: 23124791. Abstract
MAIT cells in autoimmunity. Miyake S Nihon Rinsho Meneki Gakkai Kaishi. 2012; 35(5):393-8. PMID: 23124081. Abstract
A Qualitative Study of Nutritional Behaviors in Adults With Multiple Sclerosis. Plow M, Finlayson M J Neurosci Nurs. 2012 Dec; 44(6):337-350. PMID: 23124124. Abstract
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group" Havla J, Berthele A, Kümpfel T, Krumbholz M, Jochim A, Kronsbein H, Ryschkewitsch C, Jensen P, Lippmann K, Hemmer B, et al. Mult Scler. 2012 Nov 1. PMID: 23124790. Abstract
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom A-M, Malmeström C, et al. Mult Scler. 2012 Nov 1. PMID: 23124789. Abstract
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis. Mori F, Nicoletti CG, Kusayanagi H, Foti C, Restivo DA, Marciani M G, Centonze D Brain Stimul. 2012 Oct 27. PMID: 23122918. Abstract
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL Eur J Pharmacol. 2012 Oct 30. PMID: 23123057. Abstract
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein. Inglis HR, Greer JM, McCombe PA PLoS One. 2012; 7(11):e48555. Epub 2012 Nov 06. PMID: 23139791. Abstract
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men. Gacesa JZ, Momcilovic M, Veselinovic I, Brodie DA, Grujic NG BMC Musculoskelet Disord. 2012 Nov 6; 13(1):217. Epub 2012 Nov 06. PMID: 23127247. Abstract
Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial. Saxton JM, Carter A, Daley AJ, Snowdon N, Woodroofe MN, Petty J, Roalfe A, Tosh J, Sharrack B Contemp Clin Trials. 2012 Nov 1. PMID: 23123791. Abstract
The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis. Newland PK, Thomas FP, Riley M, Flick LH, Fearing A J Neurosci Nurs. 2012 Dec; 44(6):351-357. PMID: 23124125. Abstract
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study. Quispe-Cabanillas JG, Damasceno A, Glehn F, Brandão CO, Damasceno BP, Silveira WD, Santos LM BMC Complement Altern Med. 2012 Nov 5; 12(1):209. Epub 2012 Nov 05. PMID: 23126260. Abstract
Risk of fractures in patients with multiple sclerosis: record-linkage study. Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ BMC Neurol. 2012 Nov 5; 12(1):135. Epub 2012 Nov 05. PMID: 23126555. Abstract
The pathological and physiological roles of IL-6 amplifier activation. Murakami M, Hirano T Int J Biol Sci. 2012; 8(9):1267-80. Epub 2012 Oct 25. PMID: 23136555. Abstract
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study. Ernst A, Botzung A, Gounot D, Sellal F, Blanc F, de Seze J, Manning L Mult Scler Int. 2012; 2012:820240. Epub 2012 Oct 18. PMID: 23125932. Abstract
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series. Patil NJ, Nagaratna R, Garner C, Raghuram NV, Crisan R Complement Ther Med. 2012 Dec; 20(6):424-30. Epub 2012 Oct 09. PMID: 23131373. Abstract
Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report. Peponis VG, Chatziralli IP, Parikakis EA, Chaira N, Katzakis MC, Mitropoulos PG Case Report Ophthalmol. 2012 Sep; 3(3):327-32. Epub 2012 Oct 06. PMID: 23139677. Abstract
H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis. Saligrama N, Noubade R, Case LK, Poynter ME, Teuscher C Cell Immunol. 2012 Jul; 278(1-2):27-34. Epub 2012 Jul 14. PMID: 23121973. Abstract